The journal retracts the article titled, “The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of images presented in this article [1].
In accordance with the journal’s standard procedures, the Editorial Office and Editorial Board conducted an investigation that identified indications of inappropriate image editing and duplication within Figure 5. Although the authors cooperated with the investigation, the explanations and supporting materials provided were not deemed sufficient by the Editorial Board to resolve the identified concerns. Consequently, the Editorial Board has lost confidence in the reliability of the reported findings and has decided to retract this publication.
This retraction was approved by the Editor-in-Chief of the journal Genes.
The authors have been informed of this retraction and have indicated their disagreement with this decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Wigner P., Synowiec E., Jóźwiak P., Czarny P., Białek K., Bijak M., Szemraj J., Gruca P., Papp M., Sliwinski T. RETRACTED: The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures. Genes. 2020;11:1093. doi: 10.3390/genes11091093. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]